Skip to main content
Article
Leukotriene Modifiers in the Management of Asthma
The Journal of the American Osteopathic Association
  • Manal H. Elnabtity, Detroit Medical Center
  • Renu F. Singh, Wayne State University
  • Miriam A. Ansong, Cedarville University
  • Timothy J. Craig, Pennsylvania State University
Document Type
Article
Publication Date
7-1-1999
PubMed ID
10478513
Abstract

Leukotrienes play a major role in the underlying pathophysiology of asthma. Leukotriene-receptor antagonists and direct leukotriene-synthesis inhibitors may be important new agents in maintenance therapy for asthma. Their role may also extend to attenuating exercise-induced and allergen-induced bronchospasm. This article reviews the effectiveness of available leukotriene modifiers in various clinical studies, reviews their adverse effects profile, and discusses their potential roles in the management of asthma.

Keywords
  • Asthma,
  • therapy,
  • medications,
  • adverse effects,
  • leukotriene antagonists
Citation Information
Manal H. Elnabtity, Renu F. Singh, Miriam A. Ansong and Timothy J. Craig. "Leukotriene Modifiers in the Management of Asthma" The Journal of the American Osteopathic Association Vol. 99 Iss. 7 (Supplement) (1999) p. S1 - S6 ISSN: 0098-6151
Available at: http://works.bepress.com/miriam_ansong/50/